ADVERSE REACTIONS--------------------------
6 ADVERSE REACTIONS . The following clinically significant adverse reactions are described elsewhere in labeling: Hypersensitivity [see Contraindications (4)] 6.1 Clinical Trials Experience . Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials
Download ADVERSE REACTIONS--------------------------
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION • …
www.rxabbvie.comPrior to initiating DUOPA, convert patients from all other forms of levodopa to oral immediate-release carbidopa-levodopa tablets (1:4 ratio). Patients should remain on a stable dose of their
DOSAGE AND ADMINISTRATION WARNINGS AND …
www.rxabbvie.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE CREON® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.
HIGHLIGHTS OF PRESCRIBING INFORMATION 1.In …
www.rxabbvie.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MAVYRET safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
www.rxabbvie.comFULL PRESCRIBING INFORMATION WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including SYNTHROID, either alone or …
MEDICATION GUIDE - RxAbbVie
www.rxabbvie.comMEDICATION GUIDE HUMIRA® (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before you start taking it …
MEDICATION GUIDE - RxAbbVie
www.rxabbvie.comMEDICATION GUIDE HUMIRA® (Hu-MARE-ah) (adalimumab) injection Read the Medication Guide that comes with HUMIRA before …
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.rxabbvie.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TECHNIVIE safely and effectively. See full …
VENCLEXTA (venetoclax tablets) for oral use or after ...
www.rxabbvie.comPatients should continue VENCLEXTA 400 mg once daily for 24 months from Cycle 1 Day 1 of rituximab. VENCLEXTA as Monotherapy The recommended dose of VENCLEXTA is 400 mg once daily after the patient has completed
LUPRON DEPOT 3.75 mg (leuprolide acetate for …
www.rxabbvie.comLUPRON DEPOT® 3.75 mg (leuprolide acetate for depot suspension) Rx only DESCRIPTION Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin-
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.rxabbvie.comFULL PRESCRIBING INFORMATION WARNING: SECONDARY EXPOSURE TO TESTOSTERONE • Virilization has been reported in children who were secondarily exposed to testosterone gel [see Warnings and Precautions (5.2) and Adverse Reactions (6.2)]. • Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel [see Dosage and Administration (2.2) and Warnings …
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.alnylam.com-----ADVERSE REACTIONS----- The most frequently reported adverse reactions (that occurred in at -treated patients and at least 3% more frequently than on placebo) were upper respiratory tract infections and infusion-related reactions (6.1) To report SUSPECTED ADVERSE REACTIONS, contact